Increased hepatoprotective effects of the novel farnesoid X receptor agonist INT-787 versus obeticholic acid in a mouse model of nonalcoholic steatohepatitis.
Saved in:
| Title: | Increased hepatoprotective effects of the novel farnesoid X receptor agonist INT-787 versus obeticholic acid in a mouse model of nonalcoholic steatohepatitis. |
|---|---|
| Authors: | Adorini, Luciano1 (AUTHOR), Rigbolt, Kristoffer2 (AUTHOR), Feigh, Michael2 (AUTHOR), Roth, Jonathan1 (AUTHOR), Erickson, Mary1 (AUTHOR) mary.erickson@interceptpharma.com |
| Source: | PLoS ONE. 4/25/2024, Vol. 19 Issue 4, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0300809 |
